Saturday 17 October 2026
Export ICLR’s income statement to Excel — free account
ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024. In the quarter to June 2026, revenue grew 1.20%, EPS fell 59.3%, free cash flow grew 109.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
170.18
4.95
−2.83%
Follow ICLR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 0.45% | 1.84% | 2.46% | 6.01% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 6 | 5 | |
| 0.26% | 1.05% | 1.39% | 3.41% | ||
ROIC |
1.57% | 2.04% | 2.32% | 3.95% | |
Return on Tangible Assets |
21.23% | 21.07% | 32.71% | 98.98% | |
Average Days of Receivables |
72.65 | 70.93 | 73.10 | 69.88 | |
Free Cash Flow per Share |
11.50 | 9.91 | 10.99 | 12.46 | |
Free Cash Flow |
883.82 | 758.89 | 861.99 | 964.18 | |
Capital Expenditures |
(186.22) | (176.08) | (174.21) | (176.17) | |
| Other line items | |||||
Cash ROIC |
6.45% | 5.64% | 6.51% | 7.30% | |
Accounts Receivable Turnover |
5.21 | 5.26 | 5.14 | 5.15 | |
Accounts Payable Turnover |
59.33 | 56.72 | 33.28 | 52.93 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
6.84 | 5.89 | 11.54 | 7.12 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.61) | (0.13) | (0.09) | (0.02) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.30% | 9.46% | 9.45% | 9.35% | |
Share Based Compensation of Revenue |
1.45% | 1.42% | 1.24% | 0.96% | |
Interest Coverage |
1.51 | 1.97 | 2.24 | 3.89 | |
Operating CF/Net income |
25.27 | 5.40 | 4.52 | 1.99 | |
Depreciation/Fixed assets |
0.96 | 0.98 | 0.97 | 0.99 | |
Capex/Depreciation |
(0.50) | (0.47) | (0.45) | (0.45) | |
Revenue per Share |
107.94 | 107.99 | 105.21 | 103.98 | |
Operating CF per Share |
13.92 | 12.21 | 13.21 | 14.74 | |
Capex per Share |
(2.42) | (2.30) | (2.22) | (2.28) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates